ASN002

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis

Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema

Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma